Last reviewed: June 8, 2026
Last updated: June 8, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed to treat type 2 diabetes, but clinical trials have demonstrated significant weight loss benefits in people with obesity. The medication works by mimicking a natural hormone that regulates appetite and blood sugar, leading to reduced calorie intake and sustained weight reduction. PlexusDx delivers compounded semaglutide injections starting at $149 per month, offering a personalized alternative for those seeking weight management support.
How Semaglutide Reduces Appetite and Body Weight
Semaglutide activates GLP-1 receptors in the hypothalamus, the brain region responsible for hunger regulation. This activation signals fullness earlier during meals, reducing the amount of food a person naturally consumes. Studies show that patients using semaglutide experience decreased cravings for high-calorie foods and improved satiety, meaning they feel satisfied with smaller portions.
The medication also slows gastric emptying—the rate at which food moves from the stomach into the small intestine. This delayed digestion prolongs the feeling of fullness, further suppressing appetite. Additionally, semaglutide influences reward pathways in the brain, making high-fat and high-sugar foods less appealing to many users. These combined mechanisms create a powerful metabolic shift that supports consistent weight loss over time.
Clinical Evidence: Semaglutide Weight Loss Results
The STEP trials, large randomized controlled studies published between 2021 and 2022, demonstrated that participants taking semaglutide lost 10–22% of their baseline body weight over 68 weeks, depending on the dose used. In comparison, participants receiving placebo lost only 2–3% of their body weight. These results represent one of the most significant weight loss outcomes achieved in pharmaceutical interventions for obesity management.
Beyond weight reduction, semaglutide users also showed improvements in cardiometabolic health markers, including lower blood pressure, improved cholesterol profiles, and better blood sugar control. Long-term data suggests that continued use maintains weight loss, while discontinuation typically results in weight regain. This indicates that semaglutide works best as part of a sustained treatment plan rather than a short-term intervention.
Semaglutide vs. Ozempic: Key Differences and Uses
Ozempic is a brand-name version of semaglutide manufactured by Novo Nordisk and approved by the FDA for type 2 diabetes management. While Ozempic contains the same active ingredient, it carries a higher price tag due to brand recognition and marketing costs. PlexusDx compounded semaglutide injections provide an identical chemical compound formulated by licensed 503A compounding pharmacies, delivering the same therapeutic benefits at a fraction of the cost—starting at $149 per month.
Semaglutide for weight loss is sometimes prescribed off-label from Ozempic, though Novo Nordisk also markets Wegovy, a semaglutide product specifically indicated for chronic weight management. Compounded semaglutide offers the same FDA-grade quality standards and efficacy as brand products, without the insurance requirement or membership fees. PlexusDx patients can access semaglutide through HSA and FSA accounts, making personalized GLP-1 therapy more financially accessible.
Personalized Semaglutide Therapy: The Role of Genetic Testing
Not everyone responds identically to semaglutide, and genetic variation plays a significant role in treatment effectiveness. PlexusDx Precision Peptide Genetic Test analyzes key variants including GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609—genes that directly influence GLP-1 sensitivity and metabolic response. Understanding your genetic profile helps predict which GLP-1 therapy (semaglutide, tirzepatide, or combination protocols) will deliver optimal results for your body.
Patients with certain genetic predispositions may experience faster weight loss, fewer side effects, or better long-term outcomes with semaglutide compared to other GLP-1 options. The Precision Peptide Genetic Test adds $99 after the first month of treatment and maps 14 metabolic pathways and 49 peptides to create a truly personalized treatment strategy. This data-driven approach eliminates guesswork and ensures that each patient receives the most effective medication at the right dose for their unique biology.
Side Effects and Safety Considerations for Semaglutide Users
Common side effects of semaglutide include nausea, vomiting, diarrhea, and constipation, particularly during the first 2–4 weeks of treatment or when increasing the dose. These gastrointestinal effects typically subside as the body adjusts to the medication. Most side effects are mild to moderate and do not require treatment discontinuation. Starting with a low dose and gradually titrating upward—a process PlexusDx supports—minimizes adverse reactions while allowing the body to acclimate.
Serious but rare complications include acute pancreatitis, gallbladder issues, and kidney problems in patients with severe dehydration. Semaglutide is not recommended for individuals with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2. Pregnant women should discontinue semaglutide, as safety data in pregnancy remains limited. PlexusDx patients receive comprehensive medical consultations to identify contraindications and ensure safe, appropriate use tailored to individual health status.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is semaglutide safe for long-term weight loss?
Yes, semaglutide is safe for long-term use when prescribed by a qualified healthcare provider. Clinical trials show sustained weight loss with continued treatment over 2+ years, and serious adverse events remain uncommon. PlexusDx coordinates care through licensed compounding pharmacies and includes medical oversight to monitor your response and adjust dosing as needed.
How much weight can I expect to lose with semaglutide?
Individual results vary, but STEP trial data shows average weight loss of 10–22% of baseline body weight over 68 weeks depending on dose. Some patients achieve greater loss, while others experience more modest reductions. Your genetic profile, diet, exercise, and starting weight all influence outcomes—this is why PlexusDx offers the Precision Peptide Genetic Test to predict your likely response.
What does PlexusDx semaglutide cost, and do I need insurance?
PlexusDx compounded semaglutide injections start at $149 per month with no insurance required and no membership fees. Your dose may need to go up; your price won't. The medication is HSA and FSA eligible, making it even more affordable for eligible patients.
How does PlexusDx semaglutide differ from brand-name Ozempic or Wegovy?
PlexusDx semaglutide contains the identical active compound, formulated by licensed 503A compounding pharmacies to the same standards as brand products. The key difference is cost—PlexusDx patients pay a fraction of brand-name prices while receiving the same quality and efficacy, plus the option of personalized genetic testing.
Can genetic testing predict if semaglutide will work for me?
The PlexusDx Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that directly influence semaglutide sensitivity and weight loss potential. This $99 test, taken after your first month of treatment, maps 150+ genetic insights across 14 metabolic pathways to optimize your therapy and predict whether semaglutide or an alternative GLP-1 medication like tirzepatide may be more effective.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Does GLP-1 Slow Down Digestion? Understanding the Mechanism and Its Impact on Weight Management
Can You Gain Weight with Semaglutide? Understanding the Complexities